234 related articles for article (PubMed ID: 26306937)
41. Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study.
Pipis M; Feely SME; Polke JM; Skorupinska M; Perez L; Shy RR; Laura M; Morrow JM; Moroni I; Pisciotta C; Taroni F; Vujovic D; Lloyd TE; Acsadi G; Yum SW; Lewis RA; Finkel RS; Herrmann DN; Day JW; Li J; Saporta M; Sadjadi R; Walk D; Burns J; Muntoni F; Ramchandren S; Horvath R; Johnson NE; Züchner S; Pareyson D; Scherer SS; Rossor AM; Shy ME; Reilly MM;
Brain; 2020 Dec; 143(12):3589-3602. PubMed ID: 33415332
[TBL] [Abstract][Full Text] [Related]
42. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
Lawson VH; Graham BV; Flanigan KM
Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial GTPase mitofusin 2 mutations in Korean patients with Charcot-Marie-Tooth neuropathy type 2.
Cho HJ; Sung DH; Kim BJ; Ki CS
Clin Genet; 2007 Mar; 71(3):267-72. PubMed ID: 17309650
[TBL] [Abstract][Full Text] [Related]
44. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
Cartoni R; Martinou JC
Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
[TBL] [Abstract][Full Text] [Related]
45. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
[TBL] [Abstract][Full Text] [Related]
46. MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.
Stuppia G; Rizzo F; Riboldi G; Del Bo R; Nizzardo M; Simone C; Comi GP; Bresolin N; Corti S
J Neurol Sci; 2015 Sep; 356(1-2):7-18. PubMed ID: 26143526
[TBL] [Abstract][Full Text] [Related]
47. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
[TBL] [Abstract][Full Text] [Related]
48. Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutations.
Codron P; Chevrollier A; Kane MS; Echaniz-Laguna A; Latour P; Reynier P; Bonneau D; Verny C; Procaccio V; Lenaers G; Cassereau J
J Peripher Nerv Syst; 2016 Dec; 21(4):365-369. PubMed ID: 27706887
[TBL] [Abstract][Full Text] [Related]
49. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
Elife; 2023 Nov; 12():. PubMed ID: 37910431
[TBL] [Abstract][Full Text] [Related]
50. Phenotypic spectrum of MFN2 mutations in the Spanish population.
Casasnovas C; Banchs I; Cassereau J; Gueguen N; Chevrollier A; Martínez-Matos JA; Bonneau D; Volpini V
J Med Genet; 2010 Apr; 47(4):249-56. PubMed ID: 19889647
[TBL] [Abstract][Full Text] [Related]
51. A novel MFN2 mutation causes variable clinical severity in a multi-generational CMT2 family.
Dankwa L; Richardson J; Motley WW; Scavina M; Courel S; Bardakjian T; Züchner S; Scherer SS
Neuromuscul Disord; 2019 Feb; 29(2):134-137. PubMed ID: 30642740
[TBL] [Abstract][Full Text] [Related]
52. Semi-dominant mutations in MFN2-related neuropathy and implications for genetic counselling.
Tomaselli PJ; Rossor AM; Polke JM; Poh R; Blake J; Reilly MM
J Peripher Nerv Syst; 2016 Mar; 21(1):52-4. PubMed ID: 26930221
[No Abstract] [Full Text] [Related]
53. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.
Ouvrier R; Grew S
Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430
[TBL] [Abstract][Full Text] [Related]
54. Spectrum and frequencies of mutations in the MFN2 gene and its phenotypical expression in Czech hereditary motor and sensory neuropathy type II patients.
Brožková DŠ; Posádka J; Laššuthová P; Mazanec R; Haberlová J; Sišková D; Sakmaryová I; Neupauerová J; Seeman P
Mol Med Rep; 2013 Dec; 8(6):1779-84. PubMed ID: 24126688
[TBL] [Abstract][Full Text] [Related]
55. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
Baloh RH; Schmidt RE; Pestronk A; Milbrandt J
J Neurosci; 2007 Jan; 27(2):422-30. PubMed ID: 17215403
[TBL] [Abstract][Full Text] [Related]
56. Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria.
Klein CJ; Kimmel GW; Pittock SJ; Engelstad JE; Cunningham JM; Wu Y; Dyck PJ
Arch Neurol; 2011 Oct; 68(10):1295-302. PubMed ID: 21987543
[TBL] [Abstract][Full Text] [Related]
57. Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene.
Marchesi C; Ciano C; Salsano E; Nanetti L; Milani M; Gellera C; Taroni F; Fabrizi GM; Uncini A; Pareyson D
Neuromuscul Disord; 2011 Feb; 21(2):129-31. PubMed ID: 20951041
[TBL] [Abstract][Full Text] [Related]
58. A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease.
Wang YW; Han WT; Jiang M; Lu CX; Li XF; Zhang X; Li JX
Genet Mol Res; 2012 May; 11(2):1454-9. PubMed ID: 22653593
[TBL] [Abstract][Full Text] [Related]
59. Clinical and genetic features of a cohort of patients with MFN2-related neuropathy.
Abati E; Manini A; Velardo D; Del Bo R; Napoli L; Rizzo F; Moggio M; Bresolin N; Bellone E; Bassi MT; D'Angelo MG; Comi GP; Corti S
Sci Rep; 2022 Apr; 12(1):6181. PubMed ID: 35418194
[TBL] [Abstract][Full Text] [Related]
60. The Effect of a Novel c.820C>T (Arg274Trp) Mutation in the Mitofusin 2 Gene on Fibroblast Metabolism and Clinical Manifestation in a Patient.
Beręsewicz M; Boratyńska-Jasińska A; Charzewski Ł; Kawalec M; Kabzińska D; Kochański A; Krzyśko KA; Zabłocka B
PLoS One; 2017; 12(1):e0169999. PubMed ID: 28076385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]